In a hurdle for China’s vaccine diplomacy in Nepal, the former’s condition for signing of a non-disclosure agreement is said to have put the Nepalese government in a fix, reports Economic Times.
The non-disclosure agreement would imply a legally binding contract under which Nepal will not be making details like pricing public. Other such details in the agreement could also include trade secrets, intellectual property, product formulas, information about products under development, computer code, financial information, and contractual agreements with other companies and proprietary information.
The Nepalese government is expecting to hear back from Chinese vaccine maker Sinopharm on aspects like quantity, price and delivery schedule only after the non-disclosure agreement is signed.
This gains significance as, as per Nepal’s Public Procurement Monitoring Office, except in the situation of the Government procuring defence-related materials, details of procurement must be disclosed under the Nepalese law.
This comes as a hurdle for China to push the use of its vaccines in India’s neighbourhood.
An appeal from Swarajya
At Swarajya, we rely on our readers' support through subscriptions to sustain our media platform. Unlike larger conglomerates, we are unable to relentlessly chase advertising money — our model is largely built on your patronage.
Your support has never been more crucial. We work tirelessly to deliver 10-15 high-quality articles daily, ensuring you receive insightful content from 7 AM to 10 PM.
If you believe India's story has to be articulated in a way it has never been done before without shrugging it off, become a patron (or) subscribe now for ₹̶2̶4̶0̶0̶ ₹1999 and get 12 print issues, unlimited digital access for 1 year, a special India that is Bharat T-shirt (Offer ends soon).
We are counting on you!